SCHEMBL311598

SCHEMBL311598

CCOC(=O)Nc1cc(O)cnc1-c1cc(=O)c2cc(O)ccc2o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 6/20 0.46
CSNK2B P67870 6/20 0.46
CSNK2A1 P68400 6/20 0.46
HPGD P15428 5/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 2/20 0.45
HSD17B10 Q99714 2/20 0.45
MAPT P10636 5/20 0.44
CYP3A4 P08684 4/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
TP53 P04637 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
THRB P10828 1/20 0.44
ALOX15 P16050 1/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
IP6K2 Q9UHH9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311971 0.92 AKR1B1 (0.51) HPGDKDM4ELMNAHSD17B10CYP3A4
SCHEMBL312875 0.90 KDM4E (0.58) CSNK2A2CSNK2BCSNK2A1HPGDKDM4E
SCHEMBL311791 0.84 HPGD (0.51) CSNK2A2CSNK2BCSNK2A1HPGDKDM4E
SCHEMBL313038 0.83 HPGD (0.46) CSNK2A2CSNK2BCSNK2A1HPGDKDM4E
SCHEMBL311513 0.83 AR (0.45) HPGDKDM4ELMNAHSD17B10MAPT
SCHEMBL312402 0.82 HPGD (0.43) HPGDKDM4ELMNAHSD17B10NPC1
SCHEMBL311904 0.80 HPGD (0.40) HPGDKDM4ELMNAHSD17B10MAPT
SCHEMBL312670 0.79 HPGD (0.42) CSNK2A2CSNK2BCSNK2A1HPGDKDM4E
SCHEMBL312259 0.78 MAOB (0.40) HPGDKDM4ELMNAHSD17B10NPC1
SCHEMBL312060 0.77 HPGD (0.44) CSNK2A2CSNK2BCSNK2A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed